Ferguson Kenneth M. 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jul 3, 2023
Insider Transaction Report
Form 4
Ferguson Kenneth M.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-30+42,438→ 42,438 totalExercise: $0.59From: 2024-06-30Exp: 2033-06-30→ Common Stock (42,438 underlying) - Award
Common Stock
2023-06-30+21,219→ 44,952 total
Footnotes (2)
- [F1]The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024.
- [F2]These securities were granted to Dr. Ferguson for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.